Yoo Hoon Kim

Title: Yoo Hoon Kim: Innovator in Pharmaceutical Formulations

Introduction

Yoo Hoon Kim is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the stability and efficacy of treatments for various diseases. With a total of 2 patents, his work is recognized for its potential impact on medical therapies.

Latest Patents

Yoo Hoon Kim's latest patents include a pharmaceutical formulation comprising an anti-epidermal growth factor receptor (EGFR) antibody. This formulation is characterized by low turbidity and stability, making it suitable for treating disorders such as cancer. Another significant patent involves a novel crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate. This crystalline form exhibits excellent stability in high-temperature and humidity environments, which is beneficial for preventing or treating diseases like thrombosis and myocardial infarction.

Career Highlights

Throughout his career, Yoo Hoon Kim has worked with reputable companies such as the Green Cross Corporation and Legochem Biosciences, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and formulations.

Collaborations

Yoo Hoon Kim has collaborated with notable colleagues, including Jungsub Choi and Yong Woon Choi. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Yoo Hoon Kim stands out as an influential inventor in the pharmaceutical industry, with patents that promise to advance treatment options for serious health conditions. His work exemplifies the importance of innovation in medicine and its potential to improve patient outcomes.